Spark Therapeutics, Inc.
Spark Therapeutics, Inc. is listed as the manufacturer on 1 FDA drug label records covering 1 distinct active ingredients predominantly human prescription drug products.
About Spark Therapeutics, Inc.
Spark Therapeutics, Inc. is named as the labeler on 1 FDA drug label records. Its catalogue spans 1 distinct active ingredients, led by VORETIGENE NEPARVOVEC-RZYL. Most of these labels are human prescription drug products. Labelling across this portfolio most often references: adeno-associated virus, vector-based gene, therapy indicated, treatment patients, confirmed biallelic, rpe mutation-associated, retinal dystrophy, cells determined. Use the table below to identify a specific product, then open it for full indications, dosage and warnings as filed with the FDA.
Active ingredients in this portfolio
| Active ingredient | Products |
|---|---|
| VORETIGENE NEPARVOVEC-RZYL | 1 |
FDA drug products from Spark Therapeutics, Inc.
| Brand name | Generic | Type | Route |
|---|---|---|---|
| LUXTURNA | VORETIGENE NEPARVOVEC-RZYL | HUMAN PRESCRIPTION DRUG |
Frequently asked questions
How many FDA drug products does Spark Therapeutics, Inc. make?
1 FDA drug label records name Spark Therapeutics, Inc. as the manufacturer, covering 1 distinct active ingredients.
What active ingredients does Spark Therapeutics, Inc. produce?
The most frequent active ingredients in this portfolio are VORETIGENE NEPARVOVEC-RZYL.
Are Spark Therapeutics, Inc. products prescription or over-the-counter?
The largest share of this company’s labels are human prescription drug products; check each product page for its own marketing status.
Does this page list prices or where to buy?
No. This is a labelling reference built from FDA data. It does not sell, price or recommend any medicine.
Labelling data reproduced from FDA Structured Product Labelling for identification only. This site does not sell, price or recommend any medicine.